Bio-Rad Laboratories, Inc.
BIO stock score: 54/100
$363.50 · +0.83% · Scored Oct 22, 2026
- Technical
- 60
- Fundamental
- 48
- News
- 52
The reading
Bio-Rad Laboratories (BIO) scores 54 out of 100, which reads neutral, higher than 72% of Healthcare stocks and 55% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 60, fundamentals 48.
Among the fundamentals, Fund Ownership at 100 and Earnings Growth (Annual) at 100 score highest, while PEG Ratio at 4 weighs the most against it.
On the daily chart, trend-following indicators average 49 and contrarian oscillators 59.
News sentiment is neutral at 52; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 50 to 67, and it is down 12 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward BIO’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
48Pulling it up
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
- Earnings Growth (Annual)100
Annual earnings growth tracks year-over-year profit expansion.
- Current Ratio96
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- PEG Ratio4
PEG ratio divides the P/E ratio by earnings growth rate.
- Fair Value12
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Revenue Growth (5-Year)16
5-year revenue growth analyzes long-term sales trajectory and consistency.
40 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
53Pulling it up
- EMA 50 Cross Up100
EMA 50 Cross Up detects when price crosses above the 50-period EMA.
- SMA 20091
Simple Moving Average (200-period) is the most widely followed long-term trend indicator.
- EMA 20086
Exponential Moving Average (200-period) is a crucial long-term trend indicator that reacts faster than SMA-200.
Holding it back
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- TRIX5
TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.
- SMA 50 Cross Up17
SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 52
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 55 | 1 |
| Daily | 53 | 3 |
| Weekly | 64 | 2 |
| Monthly | 66 | 2 |
| Quarterly | 65 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 54 |
| Oct 21, 2026 | 53 |
| Oct 20, 2026 | 53 |
| Oct 19, 2026 | 52 |
| Oct 18, 2026 | 53 |
| Oct 17, 2026 | 53 |
| Oct 16, 2026 | 52 |
| Oct 15, 2026 | 54 |
| Oct 14, 2026 | 54 |
| Oct 13, 2026 | 54 |
| Oct 12, 2026 | 55 |
| Oct 11, 2026 | 54 |
| Oct 10, 2026 | 54 |
| Oct 9, 2026 | 55 |
| Oct 8, 2026 | 53 |
| Oct 7, 2026 | 54 |
| Oct 6, 2026 | 56 |
| Oct 5, 2026 | 56 |
| Oct 4, 2026 | 54 |
| Oct 3, 2026 | 54 |
| Oct 2, 2026 | 54 |
| Oct 1, 2026 | 53 |
| Sep 30, 2026 | 55 |
| Sep 29, 2026 | 56 |
| Sep 28, 2026 | 56 |
| Sep 27, 2026 | 57 |
| Sep 26, 2026 | 57 |
| Sep 25, 2026 | 57 |
| Sep 24, 2026 | 58 |
| Sep 23, 2026 | 58 |
| Sep 22, 2026 | 56 |
| Sep 21, 2026 | 56 |
| Sep 20, 2026 | 56 |
| Sep 19, 2026 | 56 |
| Sep 18, 2026 | 56 |
| Sep 17, 2026 | 57 |
| Sep 16, 2026 | 57 |
| Sep 15, 2026 | 56 |
| Sep 14, 2026 | 55 |
| Sep 13, 2026 | 55 |
| Sep 12, 2026 | 55 |
| Sep 11, 2026 | 55 |
| Sep 10, 2026 | 54 |
| Sep 9, 2026 | 55 |
| Sep 8, 2026 | 57 |
| Sep 7, 2026 | 57 |
| Sep 6, 2026 | 57 |
| Sep 5, 2026 | 57 |
| Sep 4, 2026 | 57 |
| Sep 3, 2026 | 58 |
| Sep 2, 2026 | 58 |
| Sep 1, 2026 | 56 |
| Aug 31, 2026 | 56 |
| Aug 30, 2026 | 57 |
| Aug 29, 2026 | 57 |
| Aug 28, 2026 | 56 |
| Aug 27, 2026 | 57 |
| Aug 26, 2026 | 57 |
| Aug 25, 2026 | 58 |
| Aug 24, 2026 | 58 |
| Aug 23, 2026 | 58 |
| Aug 22, 2026 | 58 |
| Aug 20, 2026 | 59 |
| Aug 19, 2026 | 58 |
| Aug 18, 2026 | 57 |
| Aug 17, 2026 | 57 |
| Aug 16, 2026 | 58 |
| Aug 15, 2026 | 58 |
| Aug 14, 2026 | 57 |
| Aug 13, 2026 | 58 |
| Aug 12, 2026 | 58 |
| Aug 11, 2026 | 59 |
| Aug 10, 2026 | 59 |
| Aug 9, 2026 | 59 |
| Aug 8, 2026 | 59 |
| Aug 7, 2026 | 56 |
| Aug 6, 2026 | 50 |
| Aug 5, 2026 | 50 |
| Aug 3, 2026 | 56 |
| Aug 2, 2026 | 52 |
| Jul 31, 2026 | 53 |
| Jul 30, 2026 | 54 |
| Jul 29, 2026 | 54 |
| Jul 28, 2026 | 67 |
| Jul 27, 2026 | 66 |
| Jul 26, 2026 | 66 |
| Jul 25, 2026 | 66 |
Key facts
- Market cap
- $9.7B
- Sector
- Healthcare
- Industry
- Medical Devices
- Beta
- 1.07
- Risk grade (1–10)
- 9
- Next earnings
- Nov 4, 2026
Medical Devices peers
| Company | Market cap | Score |
|---|---|---|
| SNN Smith & Nephew | $12.2B | 54 |
| GMED Globus Medical | $10.6B | 66 |
| GKOS Glaukos | $10.4B | 54 |
| TXG 10x Genomics | $9.8B | 50 |
| PODD Insulet | $9.8B | 54 |
| BRKR Bruker | $9.0B | 50 |
Questions
What is BIO's stock score today?
BIO scores 54/100 (Neutral) as of Oct 22, 2026: technical 60, fundamental 48, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.
Is BIO a buy?
The score is not a buy or sell recommendation. A 54 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the BIO score calculated?
101 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.